ETF Managers Group, LLC Codiak Bio Sciences, Inc. Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$2.24 - $6.96 $723 - $2,248	323 Added 4.76%	7,107 $26,000
Q1 2022 May 13, 2022	BUY	$4.3 - $12.95 $98 - $297	23 Added 0.34%	6,784 $43,000
Q4 2021 Feb 14, 2022	SELL	$10.0 - $16.78 $10,070 - $16,897	-1,007 Reduced 12.96%	6,761 $74,000
Q3 2021 Nov 15, 2021	BUY	$15.58 - $22.88 $19,708 - $28,943	1,265 Added 19.45%	7,768 $125,000
Q2 2021 Aug 16, 2021	SELL	$11.72 - $26.81 $1,172 - $2,681	-100 Reduced 1.51%	6,503 $123,000
Q1 2021 May 17, 2021	SELL	$13.49 - $31.53 $34,062 - $79,613	-2,525 Reduced 27.66%	6,603 $92,000
Q4 2020 Feb 16, 2021	BUY	$7.9 - $32.3 $72,111 - $294,834	9,128 New	9,128 $256,000

238K

Ticker CDAK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,995,200
Market Cap $360K
Description
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.